These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28328244)

  • 1. [Adherence to statins in patients with myocardial infarction in Hungary].
    Tomcsányi J
    Orv Hetil; 2017 Mar; 158(12):443-446. PubMed ID: 28328244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adherence to statins in patients with myocardial infarction in Hungary. [Orvosi Hetilap (2017; 158: 443-446.); DOI: 10.1556/650.2017.30687]].
    Tomcsányi J
    Orv Hetil; 2017 May; 158(21):839. PubMed ID: 28530455
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
    Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
    JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
    O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
    Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
    Ji MS; Jeong MH; Ahn YK; Kim SH; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Int J Cardiol; 2016 Dec; 225():50-59. PubMed ID: 27710803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
    Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
    Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
    Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
    JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low persistence of simvastatin and ezetimibe fixed combination in the lipid lowering therapy].
    Simonyi G; Ferenci T
    Orv Hetil; 2015 Jan; 156(4):141-5. PubMed ID: 25597318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
    J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P; Pierard LA; Scheen AJ
    Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy　- An Observational Pharmacy Claims Database Study.
    Umeda T; Hayashi A; Fujimoto G; Piao Y; Matsui N; Tokita S
    Circ J; 2019 Jul; 83(8):1689-1697. PubMed ID: 31281135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients.
    Descamps O; Tomassini JE; Lin J; Polis AB; Shah A; Brudi P; Hanson ME; Tershakovec AM
    Atherosclerosis; 2015 Jun; 240(2):482-9. PubMed ID: 25913444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).
    Ferrières J; Bataille V; Leclercq F; Geslin P; Ruidavets JB; Grollier G; Bernard P; Cambou JP; Simon T; Danchin N
    Atherosclerosis; 2009 Jun; 204(2):491-6. PubMed ID: 19004441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Adherence and Mortality in Patients Aged 80 Years and Older After Acute Myocardial Infarction.
    Phan DQ; Duan L; Lam B; Hekimian A; Wee D; Zadegan R; Lee MS
    J Am Geriatr Soc; 2019 Oct; 67(10):2045-2049. PubMed ID: 31206603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
    Austin PC; Mamdani MM; Juurlink DN; Alter DA; Tu JV
    Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study.
    Pauriah M; Elder DH; Ogston S; Noman AY; Majeed A; Wyatt JC; Choy AM; Macdonald TM; Struthers AD; Lang CC
    Heart; 2014 Jun; 100(11):867-72. PubMed ID: 24553389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.